These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27695315)

  • 1. Breakdown of lung framework and an increase in pores of Kohn as initial events of emphysema and a cause of reduction in diffusing capacity.
    Yoshikawa A; Sato S; Tanaka T; Hashisako M; Kashima Y; Tsuchiya T; Yamasaki N; Nagayasu T; Yamamoto H; Fukuoka J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2287-2294. PubMed ID: 27695315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer coefficients better reflect emphysematous changes than carbon monoxide diffusing capacity in obstructive lung diseases.
    Shimizu K; Konno S; Makita H; Kimura H; Kimura H; Suzuki M; Nishimura M
    J Appl Physiol (1985); 2018 Jul; 125(1):183-189. PubMed ID: 29648520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body position, membrane diffusing capacity and pulmonary capillary blood volume in chronic bronchitis and pulmonary emphysema.
    Chou KC; Chang SC; Chang HI; Shiao GM
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr; 62(4):209-16. PubMed ID: 10367481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
    Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between diffusing capacity for carbon monoxide (DLCO), and quantitative computed tomography measurements and visual assessment for chronic obstructive pulmonary disease.
    Nambu A; Zach J; Schroeder J; Jin GY; Kim SS; Kim YI; Schnell C; Bowler R; Lynch DA
    Eur J Radiol; 2015 May; 84(5):980-5. PubMed ID: 25704753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative emphysema assessment of pulmonary function impairment by computed tomography in chronic obstructive pulmonary disease.
    Wang G; Wang L; Ma Z; Zhang C; Deng K
    J Comput Assist Tomogr; 2015; 39(2):171-5. PubMed ID: 25474145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease.
    Sugiyama Y; Asai K; Yamada K; Kureya Y; Ijiri N; Watanabe T; Kanazawa H; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():765-772. PubMed ID: 28424548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion capacity of the lung for carbon monoxide - A potential marker of impaired gas exchange or of systemic deconditioning in chronic obstructive lung disease?
    Weinreich UM; Thomsen LP; Brock C; Karbing DS; Rees SE
    Chron Respir Dis; 2015 Nov; 12(4):357-64. PubMed ID: 26323278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume.
    Johnson DC
    Respir Med; 2000 Jan; 94(1):28-37. PubMed ID: 10714476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusing Capacity of Carbon Monoxide in Assessment of COPD.
    Balasubramanian A; MacIntyre NR; Henderson RJ; Jensen RL; Kinney G; Stringer WW; Hersh CP; Bowler RP; Casaburi R; Han MK; Porszasz J; Barr RG; Make BJ; Wise RA; McCormack MC
    Chest; 2019 Dec; 156(6):1111-1119. PubMed ID: 31352035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Mets OM; Schmidt M; de Koning HJ; Aalst Cv; Oudkerk M; Vliegenthart R; Ginneken Bv; van Rikxoort EM; Zanen P
    COPD; 2014 Sep; 11(5):503-9. PubMed ID: 25093696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between airflow obstruction, emphysema extent, and small airways function in COPD.
    Timmins SC; Diba C; Farrow CE; Schoeffel RE; Berend N; Salome CM; King GG
    Chest; 2012 Aug; 142(2):312-319. PubMed ID: 22345381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between pulmonary function tests, thorax HRCT, and quantitative ventilation-perfusion scintigraphy in chronic obstructive pulmonary disease.
    Demir T; Ikitimur H; Akpinar Tekgündüz S; Mutlu B; Yildirim N; Akman C; Ozmen O; Kanmaz B
    Tuberk Toraks; 2005; 53(4):347-53. PubMed ID: 16456733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Mouth Pressure on Measurement of Diffusing Capacity in the Clinical Pulmonary Function Laboratory.
    Kaminsky DA; Jarzembowski SC
    Respir Care; 2019 May; 64(5):576-581. PubMed ID: 30808724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of emphysema in COPD: a functional and radiologic study.
    Cerveri I; Dore R; Corsico A; Zoia MC; Pellegrino R; Brusasco V; Pozzi E
    Chest; 2004 May; 125(5):1714-8. PubMed ID: 15136381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD.
    Díaz AA; Pinto-Plata V; Hernández C; Peña J; Ramos C; Díaz JC; Klaassen J; Patino CM; Saldías F; Díaz O
    Respir Med; 2015 Jul; 109(7):882-9. PubMed ID: 25952774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional analysis of alveolar wall destruction in the early stage of pulmonary emphysema.
    Kobayashi Y; Uehara T; Kawasaki K; Sugano M; Matsumoto T; Matsumoto G; Honda T
    Clin Anat; 2015 Mar; 28(2):227-34. PubMed ID: 25220884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.